Ads
related to: heart failure pharmacology guidelines impact factor- Living With Heart Failure
Access a Heart Failure Guide.
Learn About Treatment Options.
- Heart Failure Stages
Access Our Heart Failure Guide.
Learn About Heart Failure Stages.
- LVAD Treatment
Free Heart Failure Treatment Guide.
Learn About LVAD Treatment Options.
- Heart Failure Treatment
Download Our Free Treatment Guide.
Discover Options for Heart Failure.
- Living With Heart Failure
Search results
Results from the WOW.Com Content Network
The Journal of Cardiac Failure is a peer-reviewed medical journal published by Elsevier on behalf of the Heart Failure Society of America. It covers cardiology. The editor-in-chief is Robert Mentz. According to the Journal Citation Reports, the journal has a 2021 impact factor of 5.712. [1]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease is a peer-reviewed open access scientific journal and an official journal of the American Heart Association. [1] Since 2015, it is also published with John Wiley & Sons .
Circulation is a scientific journal published by Lippincott Williams & Wilkins for the American Heart Association.The journal publishes articles related to research in and the practice of cardiovascular diseases, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in applied (translational) and basic research.
Sleep apnea is an under-recognized risk factor for heart failure. Uncontrolled sleep apnea may increase the risk of heart failure by up to 140%. [4] Weight reduction – through physical activity and dietary modification, as obesity is a risk factor for heart failure and left ventricular hypertrophy. Effective weight management has been shown ...
The Journal of the American College of Cardiology is a peer-reviewed medical journal covering all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the-art papers, review articles, and editorials interpreting and commenting on the research presented, published by the American College of Cardiology.
As of 2023, Annual Review of Pharmacology and Toxicology is being published as open access, under the Subscribe to Open model. [1] As of 2024, Journal Citation Reports lists the journal's 2023 impact factor as 11.2, ranking it second of 106 journal titles in the category "Toxicology" and ninth of 354 titles in the category "Pharmacology ...
Which conditions are risk factors for MACE depends on some characteristics of the investigated cohort. Established risk indicators in the general population include age, pre-existing cardiovascular disease, smoking, diabetes mellitus, elevated concentrations of triglycerides and non-HDL cholesterol concentration, reduced HDL concentration and hypertension, as, e. g., demonstrated by the ...
Cardiotonic agents are typically employed as short-term and non-routine therapies for heart failure patients. [71] They are specifically reserved for those with contractile dysfunction in the left ventricles (lower chambers of the heart), low cardiac output, and low blood pressure, placing them at risk of inadequate organ perfusion. [72]
Ads
related to: heart failure pharmacology guidelines impact factor